QUAN CAPITAL
Quan Capital discover, incubate and grow next-generation life sciences companies. Their unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Their portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significant value to patients. In addition, they are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China.
QUAN CAPITAL
Social Links:
Industry:
Finance Health Care Venture Capital
Founded:
2017-01-01
Status:
Active
Contact:
+86 21 6163 2598
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Google Universal Analytics Font Awesome Apache
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-01 | OriginCell | Quan Capital investment in Series B - OriginCell | 120 M USD |
| 2022-08-01 | Oricell Therapeutics | Quan Capital investment in Series B - Oricell Therapeutics | 120 M USD |
| 2022-06-20 | Yuanyin Bio | Quan Capital investment in Series A - Yuanyin Bio | 280 M CNY |
| 2021-12-06 | Innoforce Pharmaceuticals | Quan Capital investment in Series A - Innoforce Pharmaceuticals | 375 M CNY |
| 2021-11-29 | Yuanyin Bio | Quan Capital investment in Seed Round - Yuanyin Bio | 100 M CNY |
| 2021-09-13 | Alebund Pharmaceuticals | Quan Capital investment in Series B - Alebund Pharmaceuticals | 54.5 M USD |
| 2021-09-13 | Walking Fish Therapeutics | Quan Capital investment in Series A - Walking Fish Therapeutics | 50 M USD |
| 2021-05-18 | Interius BioTherapeutics | Quan Capital investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-05-09 | Alebund Pharmaceuticals | Quan Capital investment in Series B - Alebund Pharmaceuticals | 60 M USD |
| 2021-03-22 | Innoforce Pharmaceuticals | Quan Capital investment in Series A - Innoforce Pharmaceuticals | 625 M CNY |